Case of peritoneal tuberculosis in a 54-year-old woman with a history of type II diabetes mellitus, treated irregularly; who presented a clinical picture of abdominal distension, low weight, hyporexia, and diffuse ascites associated with omental edema. A CA-125 sample was taken with a presumed diagnosis of ovarian cancer, however, pathological studies by laparoscopy reported chronic granulomatous peritonitis of the tuberculoid type with caseous necrosis, referring to peritoneal tuberculosis, which is a rare diagnosis that represents 0 .1–0.5% of all cases of Tuberculosis. Peritoneal tuberculosis should be considered as one of the possible differential diagnoses in cases of patients presenting ascites with elevated serum CA-125 levels. However, to confirm the diagnosis it is necessary to obtain histological evidence that supports the presence of changes compatible with this disease. In ...

Chronic Kidney Disease (CKD) is a progressive condition characterized by structural and functional abnormalities in the kidneys that persist for at least 3 months and are not reversible. With a global prevalence of 11% to 13% and 11% in Peru, CKD is a silent disease that can lead to complications such as anemia due to the shortened lifespan of red blood cells, alterations in iron metabolism, and reduced erythropoietin. The use of sodium-glucose cotransporter type 2 inhibitors (SGLT2 inhibitors) has sparked interest in CKD management. Studies such as DAPA-CKD and EMPA-KIDNEY have shown that SGLT2 inhibitors improve renal and cardiovascular parameters, increasing hemoglobin levels by 0.6 g/dl. This effect is attributed to improved erythropoiesis and efficient iron utilization through hepcidin reduction. Additionally, these inhibitors reduce oxidative stress and improve nitric oxide availab...